Balaxi Pharma Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Sep-2022	Jun-2022	Mar-2022	Dec-2021
Gross Sales	86.58	86.38	82.78	89.10	61.72
Excise Duty	--	--	--	--	--
Net Sales	86.58	86.38	82.78	89.10	61.72
Other Operating Income	--	--	--	--	--
Other Income	(4.57)	4.14	3.28	4.07	(0.40)
Total Income	82.02	90.52	86.07	93.17	61.32
Total Expenditure	71.29	71.63	69.04	77.87	48.17
PBIDT	10.73	18.89	17.03	15.29	13.16
Interest	0.01	0.02	0.20	0.10	0.02
PBDT	10.71	18.87	16.84	15.19	13.14
Depreciation	0.19	0.19	0.19	0.17	0.16
Minority Interest Before NP	--	--	--	--	--
Tax	2.30	3.19	2.51	2.30	0.80
Deferred Tax	--	--	--	0.01	--
Reported Profit After Tax	8.23	15.49	14.15	12.71	12.18
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	8.23	15.49	14.15	12.71	12.18
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	8.23	15.49	14.15	12.71	12.18
EPS (Unit Curr.)	8.21	15.49	14.15	12.71	12.18
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	10.02	10	10	10	10
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	12.39	21.87	20.57	17.16	21.32
PBDTM(%)	12.37	21.84	20.34	17.05	21.29
PATM(%)	9.51	17.93	17.09	14.27	19.73

QuickLinks for Balaxi Pharmaceuticals Ltd.